Japanese Government Procurement
National Hospital Organization - Notice on the use of single tendering proceduresARIKAYCE Inhalation solution 590㎎ 180 units
This procurement is covered by the WTO Agreement on Government Procurement, Japan-EU Economic Partnership Agreement or Japan-UK Comprehensive Economic Partnership Agreement.
| Publishing date | Aug 10, 2023 |
|---|---|
| Type of notice | Notice on the use of single tendering procedures |
| Procurement entity | National Hospital Organization - Osaka |
| Classification |
0004 Medical & Pharmaceutical Products |
| Summay of notice | ⑴ Classification of the products to be procured : 4 ⑵ Nature and quantity of the products to be purchased : ① ARIKAYCE Inhalation solution 590㎎ 180 units ② EVRYSDI Dry Syrup 60㎎ 528 units ③ SPINRAZA Intrathecal injection 12㎎ 12 units ④ Viltepso Injection 250㎎ 636 units ⑤ VEKLURY for Intravenous Injection 100㎎ 588 units ⑥ ULTOMIRIS for Intravenous Infusion 300㎎/3㎖ 120 units ⑶ Expected date of the contract award : 30 September 2023 ⑷ Reasons for the use single tendering procedures as provided for in the Agreement on Government Procurement : b "Absence of Competition for Technical Reasons" ⑸ Contact Point for the notice : Contract Clerk, Planning Division, National Hospital Organization Osaka Toneyama Medical Center, 5-1-1 Toneyama, Toyonaka-shi, Osaka-fu, 560-8552, Japan. TEL 06- 6853-2001 ext. 2144 |
